Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Timothy Cross"'
Autor:
Mohamed Mohamed, Omar Elshaarawy, Timothy Cross, Petra Jenkins, Reza Ashrafi, Vijay Chidambaram, Mohit Gupta, Tehreem Chaudhry
Publikováno v:
Abstracts.
Publikováno v:
Abstracts.
Autor:
Justin Watts, Mark D. Minden, Kimo Bachiashvili, Andrew M. Brunner, Sameem Abedin, Timothy Crossman, Magdalena Zajac, Veronica Moroz, Jacqueline L. Egger, Aarti Tarkar, Brandon E. Kremer, Olena Barbash, Gautam Borthakur
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: GSK3326595 is a potent, selective, reversible protein arginine methyltransferase 5 (PRMT5) inhibitor under investigation for treatment of myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (
Externí odkaz:
https://doaj.org/article/41e271adc09543d4b1c4530ab475b544
Publikováno v:
British Journal of Biomedical Science
article-version (VoR) Version of Record
article-version (VoR) Version of Record
BACKGROUNDThe objective of this study was to evaluate the performance characteristics of early commercial SARS-CoV-2 antibody assays in mild and asymptomatic subjects to enable the selection of suitable serological assays for routine diagnostic use w
Autor:
Timothy Cross
Publikováno v:
Emergency Relief Operations ISBN: 9780823295401
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5c744290e5b462a6400d7571dca96b8
https://doi.org/10.1515/9780823295401-012
https://doi.org/10.1515/9780823295401-012
Background Assessing risk of post-surgical mortality is a key component of pre-surgical planning. The Surgical Outcome Risk Tool (SORT) uses pre-operative variables to predict 30-day mortality. The aim of this study was to externally validate SORT in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e42119733bd9235cc47c6690bcfd874a
https://doi.org/10.21203/rs.3.rs-61050/v1
https://doi.org/10.21203/rs.3.rs-61050/v1
Publikováno v:
Perioperative Medicine
Perioperative Medicine, Vol 10, Iss 1, Pp 1-9 (2021)
Perioperative Medicine, Vol 10, Iss 1, Pp 1-9 (2021)
Background Assessing the risk of post-surgical mortality is a key component of pre-surgical planning. The Surgical Outcome Risk Tool (SORT) uses pre-operative variables to predict 30-day mortality. The aim of this study was to externally validate SOR
Autor:
Amen Sibtain, Hannah C P Wilson, Patricia M Price, Christy Goldsmith, Andrew Edwards, Rhiannon Davies, Keyoumars Ashkan, Ronald Beaney, Timothy Cross, Nick P Plowman, Melanie M Green
Publikováno v:
Cureus
The study aim was to evaluate patient individualized Cyberknife® treatment for heterogeneous skull-base tumors. Patients treated between 2009 and 2013 at The Harley Street Clinic were studied. In total, 66 patients received 15–30 Gy in 1–5 fract
Autor:
David Caruso, Timothy Cross
Publikováno v:
The International Journal of Evidence & Proof. 16:364-397
Recent legislative reforms in Australia designed to address the difficulties attending the reception and treatment of child evidence will have little, if any, success because they do not address the reasons for the difficulties, nor introduce improve